Exendin Fragment 9-39
SIGMA/E7269 - ≥95% (HPLC)
CAS Number: 133514-43-9
Empirical Formula (Hill Notation): C149H234N40O47S
Molecular Weight: 3369.76
MDL Number: MFCD00283195
Linear Formula: C149H234N40O47S
Product Type: Chemical
| assay | ≥95% (HPLC) |
| form | powder |
| InChI | 1S/C149H234N40O47S/c1-14- |
| InChI key | WSEVKKHALHSUMB-MVNVRWBSSA |
| mol wt | 3369.76 g/mol |
| Quality Level | 200 ![]() |
| SMILES string | S(CC[C@H](NC(=O)[C@@H](NC |
| solubility | water: 1.00-1.04 mg/mL, clear, colorless |
| storage condition | (Keep container tightly closed in a dry and well-ventilated place) |
| storage temp. | −20°C |
| technique(s) | protein expression: suitable |
| UniProt accession no. | P01275 ![]() |
P43220 ![]() |
| Amino Acid Sequence: | Asp-Leu-Ser-Lys-Gln-Met-G |
| Application: | Exendin Fragment 9-39 has been used to study its effect on basal microvascular permeability.It has also been used as a glucagon-like peptide-1 receptor (GLP-1R) antagonist: • to study to determine whether Ex-4 a GLP-1R agonist acts through GLP-1R, in mouse skeletal muscle cell line • to study its effects on the adaptation of islets in glucose-dependent insulinotropic polypeptide knockout mice • to study its in vivo effects on GLP-1 signaling on insulin response in mice |
| Biochem/physiol Actions: | Exendin Fragment 9-39 is an antagonist of glucagon-like peptide-1 (GLP-1) receptor, and also acts as an inhibitor of the glucose-dependent insulinotropic polypeptide (GIP)-receptor binding. It also prevents the production of cAMP by GIP.GLP-1, along with GIP, acts as a physiological incretin. |
| Other Notes: | Lyophilized from 0.1% TFA in H2O |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

